Skip to main content
. Author manuscript; available in PMC: 2020 Jan 2.
Published in final edited form as: J Clin Immunol. 2019 May 14;39(4):440–447. doi: 10.1007/s10875-019-00640-5

Table 1.

Clinical and laboratory comparison between patients with CVID and XLA

CVID
N = 749
XLA
N = 320
P value*
Sex (male) 322 (43.0) 320 (100.0) < 0.001
Age at last visit 39.50 [24.90, 50.30] 17.40 [8.43, 28.25] < 0.001
Age of symptom onset 16.00 [6.00, 30.00] 1.00 [0.50, 2.15] < 0.001
Age of diagnosis 29.90 [15.20, 42.70] 2.40 [1.00, 5.60] < 0.001
CD4 664.00 [470.00, 927.00] 1576.50 [1120.00, 2426.75] < 0.001
CD8 390.00 [246.50, 681.00] 795.84 [484.56, 1241.10] < 0.001
CD19 176.00 [80.25, 309.25] 0.00 [0.00, 13.00] < 0.001
Pre-diagnostic IgG 353 [186–514] 65 [25.5–325] 0.015
IgA 9.99 [6.64, 31.00] 6.66 [0.99, 8.14] < 0.001
IgM 23.00 [10.99, 44.00] 10.00 [4.99, 22.00] < 0.001
*

Chi-square test for categorical variables and Mann-Whitney test for continuous variables

Continuous variables were summarized as median [IQR] and categorical variables were summarized as counts (percentage)